ARTICLE | Finance
With record fund flows, biotech a top sector for investors heading into 3Q20
Biotech likely to be top pick again in 3Q20, with a COVID-19 vaccine and politics the wild cards
July 10, 2020 9:01 PM UTC
Investors expect the massive inflows to biotech to continue over the next quarter as the sector is viewed as a top defensive pick in a struggling global economy that is unlikely to improve until the first COVID-19 vaccines roll out, or therapeutics gain approval that make a meaningful difference.
The broad interest in the sector means capital markets are likely to remain active even in the face of the upcoming U.S. presidential election...